Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125052922 | 12505292 | 2 | F | 20160503 | 20160628 | 20160706 | PER | US-ASTRAZENECA-2016SE49836 | ASTRAZENECA | 0.00 | F | Y | 93.40000 | KG | 20160706 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125052922 | 12505292 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 2 PUFFS TWICE A DAY | 21929 | BID | |||||||||
| 125052922 | 12505292 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 2 PUFFS TWICE A DAY | 21929 | BID | |||||||||
| 125052922 | 12505292 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 21929 | |||||||||||
| 125052922 | 12505292 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 21929 | |||||||||||
| 125052922 | 12505292 | 5 | C | OXYGEN. | OXYGEN | 1 | Nasal | 3.0L CONTINUOUSLY | 0 | 3 | L | ||||||||
| 125052922 | 12505292 | 6 | C | SPIRIVA RESPIMATE | 2 | Respiratory (inhalation) | 2.5 MCG 2 PUFFS DAILY | 0 | |||||||||||
| 125052922 | 12505292 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125052922 | 12505292 | 8 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 0 | 15 | MG | QD | ||||||||
| 125052922 | 12505292 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | .112 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125052922 | 12505292 | 1 | Chronic obstructive pulmonary disease |
| 125052922 | 12505292 | 2 | Asthma |
| 125052922 | 12505292 | 3 | Chronic obstructive pulmonary disease |
| 125052922 | 12505292 | 4 | Asthma |
| 125052922 | 12505292 | 5 | Dyspnoea |
| 125052922 | 12505292 | 6 | Chronic obstructive pulmonary disease |
| 125052922 | 12505292 | 7 | Blood cholesterol abnormal |
| 125052922 | 12505292 | 8 | Product used for unknown indication |
| 125052922 | 12505292 | 9 | Thyroid hormones increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125052922 | 12505292 | Drug dose omission | |
| 125052922 | 12505292 | Pneumonia | |
| 125052922 | 12505292 | Productive cough |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125052922 | 12505292 | 1 | 2010 | 201511 | 0 | |
| 125052922 | 12505292 | 2 | 2010 | 201511 | 0 | |
| 125052922 | 12505292 | 3 | 20160502 | 0 | ||
| 125052922 | 12505292 | 4 | 20160502 | 0 |